Leonard H Wexler MD
Professor of Clinical Pediatrics, Weill-Cornell Medical College
225 Summit AvenueMontvale, NJ 07645
Overview of Dr. Wexler
Dr. Leonard Wexler is a pediatric hematologist and oncologist based in New York City. A graduate from Boston University School of Medicine, his medical training includes internships and residencies at Montefiore Medical Center/Albert Einstein College of Medicine and Jacobi Medical Center. Dr. Wexler also completed a fellowship in pediatric hematology/oncology at the National Cancer Institute/Pediatric Oncology Branch. His research has been published in prestigious publications such as Cancer Research, Urology, and Clinical Cancer Research, and includes a focus on bone and soft tissue sarcomas, particularly rhabdomyosarcoma. He has conducted a clinical trial on high-risk rhabdomyosarcomas, using Irinotecan and Carboplatin. Dr. Wexler has received several awards, notably being named multiple times as one of America's Top Doctors by Castle Connolly.
Education & Training
National Capital ConsortiumFellowship, Pediatric Hematology/Oncology, 1988 - 1990
Jacobi Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1987 - 1988
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Pediatrics, 1986 - 1987- Jacobi Medical Center/Albert Einstein College of MedicineInternship, Pediatrics, 1985 - 1986
Boston University School of MedicineClass of 1985
Certifications & Licensure
FL State Medical License 2022 - Present
NJ State Medical License 1997 - 2027
NY State Medical License 1986 - 2027
NC State Medical License 2020 - 2022
DC State Medical License 1992 - 1997
MD State Medical License 1989 - 1995
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Top Doctors: New York Metro Area Castle Connolly, 2002-2014
- New York Magazine: Top Doctors Castle Connolly, 2005-2009, 2011, 2013-2014
Clinical Trials
Publications & Presentations
PubMed
- Step-down management of fever and neutropenia in low-risk pediatric and adolescent-young adult oncology patients is safe and effective: a single center experience.Priya H Marathe, Christine Camacho-Bydume, Charlie White, Audrey Mauguen, Michael Kinnaman
Pediatric Hematology and Oncology. 2025-12-22 - Spectrum and Clinical Impact of Secondary Genetic Alterations in Translocation-Associated Sarcomas.Hsin-Yi Chang, William Tap, Emily Slotkin, Leonard Wexler, Damon Reed
JCO Precision Oncology. 2025-10-01 - High-Dose-Rate Brachytherapy for Vaginal Rhabdomyosarcoma (RMS): Lessons Learned at a Single Institution.Kaitlyn Lapen, Kathryn R Tringale, Leonard H Wexler, Danielle N Friedman, Gil'ad N Cohen
International Journal of Radiation Oncology, Biology, Physics. 2025-09-01
Journal Articles
- MYOD1-Mutant Spindle Cell and Sclerosing Rhabdomyosarcoma: An Aggressive Subtype Irrespective of Age. A Reappraisal for Molecular Classification and Risk StratificationLeonard H Wexler, Cristina R Antonescu, Michael P LaQuaglia, Narasimhan P Agaram, Nature
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
Anthem Blue Preferred Plus POS
BCBS Alabama PPO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPOGHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust POS-SE
WEA Trust Preferred Provider Plan - Trust Pref - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
